| abstract |
The present invention relates to a compound represented by the general formula (I) and a pharmaceutically acceptable salt thereof. The compounds can be used for the manufacture of a medicament for the prevention or treatment of conditions mediated by modulation of dipeptidyl peptidase IV activity, which conditions are preferably glucose intolerance, diabetes mellitus, diabetes mellitus, diabetes and Selected from metabolic acidosis. |